Nastech The Latest Biotech To Feel The Sting Of Divorce (Investor’s Business Daily via Yahoo! News)
Nov. 6 was a bleak day for Nastech Pharmaceutical. That’s when the developer of nasally administered drugs got ditched by partner Procter & Gamble, which canceled a collaboration between the two companies to commercialize an osteoporosis nasal spray.